Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
104.74
+0.07 (+0.07%)
Official Closing Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite
March 03, 2024
There is a world of opportunities ahead for this healthcare giant.
Via
The Motley Fool
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
March 01, 2024
Via
Benzinga
Nearing Retirement? These Stocks Are as Cautious as They Come
February 28, 2024
Healthcare blue chips can provide retirees the consistency they need while growing their nest eggs further.
Via
The Motley Fool
3 Magnificent Dividend Growth Stocks to Buy Now and Hold for at Least a Decade
February 27, 2024
These stocks don't offer the highest yields, but their payouts are growing fast.
Via
The Motley Fool
3 Blue-Chip Stocks to Buy to Bolster Your Portfolio
February 26, 2024
Delve into three undervalued blue-chip stocks to buy driving growth in consumer staples, pharmaceuticals, and healthcare.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
February 26, 2024
Via
Benzinga
Could Abbott Laboratories Stock Help You Become a Millionaire?
February 26, 2024
Abbott's earnings have soared over the past decade.
Via
The Motley Fool
Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment
February 23, 2024
Via
Benzinga
Looking for Growth? 7 Hot Trends That Have Been Flying Under Investors’ Radar.
February 26, 2024
Discover 7 under-the-radar stock trends set to make waves in the stock market. Find out why savvy investors are tuning in.
Via
InvestorPlace
Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth
February 23, 2024
Explore recession-proof stocks thriving in Energy, Health Care, Industrials, and more, offering stability and growth amid economic turmoil.
Via
InvestorPlace
Abbott Laboratories Stock Gets A Healthy Technical Rating Upgrade
February 21, 2024
In a welcome move, Abbott Laboratories stock saw its Relative Strength Rating improve from 67 to 73 on Wednesday.
Via
Investor's Business Daily
Peering Into Abbott Laboratories's Recent Short Interest
February 20, 2024
Via
Benzinga
3 Cash Cows to Boost Your Confidence During the February Chill
February 18, 2024
The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns.
Via
InvestorPlace
The Smartest Dividend Stocks to Buy With $400 Right Now
February 18, 2024
These stocks reward you during any market environment.
Via
The Motley Fool
This Is What Whales Are Betting On Abbott Laboratories
February 08, 2024
Via
Benzinga
Is Abbott Laboratories Stock a Buy Now?
February 03, 2024
Can Abbott Laboratories be a reliable income stock to hang on to now?
Via
The Motley Fool
Looking At Abbott Laboratories's Recent Unusual Options Activity
January 30, 2024
Via
Benzinga
Cardiology's Quantum Leap: FDA's Advisory Panel Gives Thumbs Up To Abbott's Minimally Invasive Heart Valve Repair Device
February 14, 2024
FDA panel confirms support (13-1) for Abbott Laboratories' TriClip TEER system in treating tricuspid regurgitation. Approval decision expected from FDA in 2024.
Via
Benzinga
Exposures
Product Safety
FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom
February 12, 2024
FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document.
Via
Benzinga
Exposures
Product Safety
Abbott Laboratories Is the Latest Company to Get Involved in the Weight Loss Market. Here's How.
February 11, 2024
Abbott Labs has an impressive portfolio of nutrition drinks, and its latest addition could help it profit from a new market: people taking prescribed weight loss drugs.
Via
The Motley Fool
3 Groundbreaking Healthcare Stocks to Buy for Robust Gains
February 11, 2024
Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector.
Via
InvestorPlace
These 2 Stocks Are Trying to Ride the Ozempic Bandwagon: Are They Buys?
February 09, 2024
There's room for multiple winners in the fast-growing weight-loss market.
Via
The Motley Fool
Abbott Laboratories Stock Getting Closer To Key Technical Benchmark
February 07, 2024
Abbott Laboratories shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
Via
Investor's Business Daily
7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates
February 07, 2024
When it comes to buying dividend stocks, investors should seek out companies that consistently and repliably grow their payout over time.
Via
InvestorPlace
Want to Get Richer? Here Are the 3 Best Stocks to Buy Now and Hold Forever
February 07, 2024
Healthcare is an excellent place to find some tried and true wealth compounders.
Via
The Motley Fool
Healthcare And Life Science Funds And ETFs Performance 2023-2024
February 05, 2024
Healthcare stocks usually provide a defensive posture to a stock portfolio.
Via
Talk Markets
Topics
ETFs
2 Stocks to Buy Near Their 52-Week Highs
February 05, 2024
It's not too late to invest in these stocks.
Via
The Motley Fool
2 Healthcare Dividend Kings to Buy and Hold Forever
February 04, 2024
It's going to take a lot to interrupt these companies' streaks.
Via
The Motley Fool
Abbott Faces Lawsuit As Grandmother Questions PediaSure's Height Growth Claims
February 03, 2024
Abbott Laboratories faces a lawsuit questioning the efficacy of PediaSure Grow & Gain nutrition drinks in promoting height growth.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?
February 02, 2024
Abbott Labs is using its well-established strengths to make gains in the weight loss market.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.